Literature DB >> 23500272

Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?

Behnood Bikdeli, Kelly M Strait, Kumar Dharmarajan, Chohreh Partovian, Steven G Coca, Nancy Kim, Shu-Xia Li, Jeffrey M Testani, Usman Khan, Harlan M Krumholz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23500272      PMCID： PMC4038646          DOI： 10.1016/j.jacc.2012.12.043

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  11 in total

1.  Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.

Authors:  S Kasama; T Toyama; T Hatori; H Sumino; H Kumakura; Y Takayama; S Ichikawa; T Suzuki; M Kurabayashi
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

2.  Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.

Authors:  W Franklin Peacock; Maria Rosa Costanzo; Teresa De Marco; Margarita Lopatin; Janet Wynne; Roger M Mills; Charles L Emerman
Journal:  Cardiology       Date:  2008-10-17       Impact factor: 1.869

3.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

4.  Healthcare costs of patients with heart failure treated with torasemide or furosemide.

Authors:  K T Stroupe; M M Forthofer; D C Brater; M D Murray
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

5.  Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.

Authors:  Tohru Masuyama; Takeshi Tsujino; Hideki Origasa; Kazuhiro Yamamoto; Takashi Akasaka; Yutaka Hirano; Nobuyuki Ohte; Takashi Daimon; Satoshi Nakatani; Hiroshi Ito
Journal:  Circ J       Date:  2012       Impact factor: 2.993

6.  Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.

Authors: 
Journal:  Clin Ther       Date:  2011-09-08       Impact factor: 3.393

7.  Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.

Authors:  M D Murray; M M Deer; J A Ferguson; P R Dexter; S J Bennett; S M Perkins; F E Smith; K A Lane; L D Adams; W M Tierney; D C Brater
Journal:  Am J Med       Date:  2001-11       Impact factor: 4.965

8.  Torasemide in chronic heart failure: results of the TORIC study.

Authors:  Juan Cosín; Javier Díez
Journal:  Eur J Heart Fail       Date:  2002-08       Impact factor: 15.534

9.  Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure.

Authors:  Begoña López; Arantxa González; Javier Beaumont; Ramón Querejeta; Mariano Larman; Javier Díez
Journal:  J Am Coll Cardiol       Date:  2007-08-13       Impact factor: 24.094

10.  Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life.

Authors:  Karin Müller; Giancesare Gamba; Françoise Jaquet; Bernhard Hess
Journal:  Eur J Heart Fail       Date:  2003-12       Impact factor: 15.534
View more
  22 in total

Review 1.  A reappraisal of loop diuretic choice in heart failure patients.

Authors:  Jonathan Buggey; Robert J Mentz; Bertram Pitt; Eric L Eisenstein; Kevin J Anstrom; Eric J Velazquez; Christopher M O'Connor
Journal:  Am Heart J       Date:  2015-01-06       Impact factor: 4.749

Review 2.  Personalizing the diuretic treatment of hypertension: the need for more clinical and research attention.

Authors:  Samuel J Mann; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

Review 3.  Hypertrophy to failure: what goes wrong with the fibers of the heart?

Authors:  S K Maulik; S Mishra
Journal:  Indian Heart J       Date:  2015-03-14

4.  Clinical Pharmacology in Diuretic Use.

Authors:  David H Ellison
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-01       Impact factor: 8.237

Review 5.  Diuretic Strategies in Acute Decompensated Heart Failure.

Authors:  E Ashley Hardin; Justin L Grodin
Journal:  Curr Heart Fail Rep       Date:  2017-04

Review 6.  Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.

Authors:  Jozine M ter Maaten; Mattia A E Valente; Kevin Damman; Hans L Hillege; Gerjan Navis; Adriaan A Voors
Journal:  Nat Rev Cardiol       Date:  2015-01-06       Impact factor: 32.419

Review 7.  Diuretic Treatment in Heart Failure.

Authors:  David H Ellison; G Michael Felker
Journal:  N Engl J Med       Date:  2017-11-16       Impact factor: 91.245

8.  Older drugs with infantile evidence: the illustrative example of loop diuretics.

Authors:  Behnood Bikdeli; Jeffrey M Testani; Joseph S Ross; Harlan M Krumholz
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2018-07-01

9.  Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.

Authors:  Robert J Mentz; Jonathan Buggey; Mona Fiuzat; Mads K Ersbøll; Phillip J Schulte; Adam D DeVore; Eric L Eisenstein; Kevin J Anstrom; Christopher M OʼConnor; Eric J Velazquez
Journal:  J Cardiovasc Pharmacol       Date:  2015-05       Impact factor: 3.105

10.  Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.

Authors:  Robert J Mentz; Eric J Velazquez; Marco Metra; Colleen McKendry; Karen Chiswell; Mona Fiuzat; Michael M Givertz; Adriaan A Voors; John R Teerlink; Christopher M O'Connor
Journal:  Future Cardiol       Date:  2015-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.